MedTrace Logo

A Proof-of-Concept, Safety and Efficacy Study of SkinQ Glow Bright Wonder Mask in Healthy Human Subjects

NCT05499247 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-09-29

No results posted yet for this study

Summary

This is an open-label, single-arm, single-centre, proof-of-concept, safety and efficacy, clinical study of SkinQ Glow Bright Wonder Mask in Healthy Human Subjects and adequate representation of varied skin types \[Normal, Oily, Dry, Combined and Sensitive skin\].

The rationale of the study is to evaluate whether the product SkinQ Glow Bright Wonder Mask is providing an instant skin tanning reduction in 15 mins, smoother, softer and glows skin, and even/brighter complexion in 15 mins, instant improvement in skin brightness and not just a marketing gimmick. It is also to assess the efficacy of the product in its performance for the following parameters:

* Tan reduction
* Close pores
* Makes skin bright and radiant.
* Removes tan marks
* Fades dark spots of pimple and acne
* Gives a glowing look
* The texture of the product, experience, acceptability

Conditions

  • Healthy Human Volunteers With Visibly Tanned Skin

Interventions

OTHER

SkinQ Glow Bright Wonder Mask

Mode of Usage: Cleanse and dry face. Apply 1 tsp or 5g of the product. Apply with clean finger or brush to full face. Leave to dry for 15 minutes. Wipe with wet cotton or rinse with cool water. Route of Administration: Topical

Sponsors & Collaborators

  • NovoBliss Research Pvt Ltd

    lead OTHER

Principal Investigators

  • Dr Nayan K Patel, MBBS · Medical Director

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-29
Primary Completion
2022-09-06
Completion
2022-09-14

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05499247 on ClinicalTrials.gov